Abstract
Urinary catecholamines (DA, NE, E) and their main metabolites (HVA, DOPAC, MHPG) were analyzed both as free and conjugates in eight children diagnosed as autistic according to DSM-III criteria and eight normal children. Significant differences appeared for the urinary excretion of both DA and NE and their respective metabolites: Autistic children showed low DA, high HVA, high NE, low MHPG urinary levels. These results are consistent with previous findings on altered catecholamine metabolism in autistic children. They suggest that autistic behaviour might be related to an abnormal functional imbalance among monoamines either at a molecular level or at a system level. Furthermore, they emphasize the special interest of urinary assays in pediatric research.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
American Psychiatric Association. (1980).Diagnostic and statistical manual of mental disorders (3rd ed.). Washington, DC: Author.
Anderson, L. T., Campbell, M., Grega, D. M., Perry, R., Small, A. M., & Green, W. H. (1984). Haloperidol in the treatment of infantile autism: Effects on learning and behavioral symptoms.The American Journal of Psychiatry, 141, 1195–1202.
Campbell, M., Anderson, L. T., Small, A. M., Perry, R., Green, W. H., & Caplan, R. (1982). The effects of haloperidol on learning and behavior in autistic children.Journal of Autism and Development Disorders, 12, 167–175.
Campbell, M., Small, A. M., Collins, P. J., Friedman, E., David, R., & Genieser, N. B. (1976). Levodopa and levoamphetamine: A cross over study in schizophrenic children.Current Therapeutic Research, 18, 70–86.
Cohen, D. J., Caparulo, B. K., Shaywitz, B. A., & Bowers, M. B., Jr. (1977). Dopamine and serotonin metabolism in neuropsychiatrically disturbed children. CSF homovanillic acid and 5-hydroxyindoleacetic acid.Archives of General Psychiatry, 34, 545–550.
Cohen, D. J., Shaywitz, B. A., Johnson, W. T., & Bowers, M., Jr. (1974). Biogenic amines in autistic and atypical children. Cerebrospinal fluid measures of homovanillic acid and 5-hydroxyindolacetic acid.Archives of General Psychiatry, 31, 845–853.
Cottet-Emard, J. M., & Peyrin, L. (1982). Conjugated HVA increase in rat urine after insulin induced hypoglycemia: involvement in central dopaminergic structures but not of adrenal medulla.Journal of Neural Transmission, 55, 121–138.
Delmaz, Y., & Peyrin, L. (1982). Sex-differences in catecholamine metabolites in human urine during development and at adulthood.Journal of Neural Transmission, 54, 193–207.
Delmaz, Y., Peyrin, L., Sann, L., & Dutruge, J. (1979). Age-related changes in catecholamine metabolites of human urine from birth to adulthood.Journal of Neural Transmission, 46, 153–174.
Garnier, C., Comoy, E., Barthélémy, C., Leddet, I., Garreau, B., Muth, J. P., & Lelord, G. (1986). Dopamine beta-hydroxylase (DBH) and homovanillic acid (HVA) in autistic children.Journal of Autism and Developmental Disorders, 16, 23–29.
Garreau, B., Domenech, J., Martineau, J., Barthélémy, C., Lelord, G., & Muh, J. P. (1981). HVA and MHPG in urine of premature infants.Psychiatry Research, 5, 323–330.
Gillberg, C., Svennerholm, L., & Hamilton-Hellberg, C. (1983). Childhood psychosis and monoamine metabolites in spinal fluid.Journal of Autism and Developmental Disorders, 13, 383–396.
Kopin, I. J. (1985). Catecholamine metabolism: Basic aspects and clinical significance.Pharmacological Reviews, 37, 333–364.
Lake, C. R., Ziegler, M. G., & Murphy, D. L. (1977). Increased norepinephrine levels and decreased β-hydroxylase activity in primary autism.Archives of General Psychiatry, 34, 553–556.
Lelord, G., Callaway, E., & Muh, J. P. (1982). Therapeutic effects of high doses of vitamin B6 and magnesium on autistic symptoms.Acta Vitaminologica et Enzymologica, 4, 27–44.
Lelord, G., Callaway, E., Muh, J. P., Arlot, J. C., Sauvage, D., Garreau, B., & Domenech, J. (1978). L'acide homovanilique urinaire et ses modifications par ingestion de vitamine B6. Exploration fonctionnelle dans l'autisme de l'enfant?Revue Neurologique, Paris, 134, 797–801.
Maas, J. W., Hattox, S. E., Greene, N. M., & Landis, D. H. (1979). 3-methoxy 4-hydroxyphenylglycol production by human brain in vivo.Science, 205, 1025–1027.
Maas, J. W., Hattox, S. E., Martin, D. M., & Landis, D. H. (1979). A direct method for determining dopamine synthesis and output of dopamine metabolites from brain in awake animals.Journal of Neurochemistry, 32, 839.
Paget, M., Gontier, M., & Liefooghe, J. (1955). Recherches sur le dosage de la creatinine urinaire.Annales Biologie Clinique, 13, 535–553.
Peyrin, L., & Pequignot, J. M. (1983). Free and conjugated 3 Methoxy-4 hydroxy-phenylglycol in human urine-Peripheral origin of glucuronide.Psychopharmacology, 79, 16–20.
Peyrin, L., Simon, H., Cottet-Eymard, J. M., Bruneau, N., & Le Moal, M. (1982). 6-Hydroxydopamine lesions of dopaminergic A10 neurons. Long term effects in the urinary excretion of free and conjugated catecholamines and their metabolites in the rat.Brain Research, 235, 363–369.
Roginski, M. S., Gordon, R. D., & Bennett, M. J. (1974). A rapid and simple gas liquid chromatographic procedure for homovanillic and vanilmandelic acid in urine.Clinical Chimica Acta, 56, 261–264.
Shaywitz, B. A., Cohen, D. J., Leckman, J. F., Young, J. G., & Bowers, M. B. (1980). On-togeny of dopamine and serotonin metabolites in the cerebrospinal fluid of children with neurological disorders.Developmental Medicine and Child Neurology, 22, 748–754.
Shekim, N. D., Javaid, J., Davis, J. M., & Bylund, D. B. (1983). Urinary MHPG and HVA excretion in boys with attention deficit disorders and hyperactivity treated with deamphetamine.Biological Psychiatry, 18, 707–712.
Swann, A. C., Maas, J. W., Hattox, S. E., & Landis, H. (1980). Catecholamine metabolism in human plasma as indices of brain function: Effect of debrisoquin.Life Sciences, 25, 1857–1862.
Wadman, S. K., Ketting, D., & Voute, P. A. (1976). Gas chromatographic determination of urinary vanilglycolic acid, vaniglycol, vanilacetic acid and vanillactic acid: Chemical parameters for the diagnosis of neurogenic tumours and the evaluation of their treatment.Clinical Chimica Acta, 72, 49–68.
Young, J. G., Cohen, D. J., Brown, S. L., & Caparulo, B. K. (1978). Decreased urinary free catecholamines in childhood autism.Journal of the American Academy of Child Psychiatry, 17, 671–678.
Young, J. G., Cohen, D. J., Caparulo, B. K., Brown, S. L., & Maas, J. W. (1979). Decreased 24 hours urinary MHPG in childhood autism.American Journal of Psychiatry, 136, 1055–1057.
Young, J. G., Cohen, D. J., Kavanagh, M. E., Landis, H. D., Shaywitz, B. A., & Maas, J. W. (1981). Cerebrospinal fluid, plasma, and urinary MHPG in children.Life Sciences, 28, 2837–2845.
Young, J. G., Cohen, D. J., Shaywitz, S. E., Caparulo, R. K., Kavanagh, M. E., Hungt, R. D., Leckman, J. P., Anderson, G. M., Detlor, J., Harcherik, D., & Shaywitz, B. A. (1982). Assessment of brain function in clinical pediatric research: behavioural and biological strategies.Schizophrenia Bulletin, 8, 205–235.
Young, J. G., Kavanagh, M. E., Anderson, G. M., Shaywitz, B. A., & Cohen, D. J. (1982). Clinical neurochemistry of autism and associated disorders.Journal of Autism and Developmental Disorders, 12, 147–165.
Zametkin, A. J., Karoum, F., Linnoila, M., Rapoport, J. L., Brown, G. L., Chuang, L. N., & Wyatt, R. J. (1985). Stimulants, urinary catecholamines, and indoleamines in hyperactivity.Archives of General Psychiatry, 42, 251–255.
Author information
Authors and Affiliations
Additional information
This work was supported by CNRS (ER 196 and ERA-N 697, “Biology and Neuropsychiatry”), INSERM ATP 78-97, Social Security, 1982–1983, and Fondation Langlois. We thank Mrs. Barre, Mrs. Lardeux, Mrs. Lehn, and Miss Renon for their technical work.
Rights and permissions
About this article
Cite this article
Barthelemy, C., Bruneau, N., Cottet-Eymard, J.M. et al. Urinary free and conjugated catecholamines and metabolites in autistic children. J Autism Dev Disord 18, 583–591 (1988). https://doi.org/10.1007/BF02211876
Issue Date:
DOI: https://doi.org/10.1007/BF02211876